Mitsui & Co., Ltd. (hereinafter called "Mitsui", President and CEO: Tatsuo Yasunaga) indirectly owns a share in International Columbia U.S. LLC (hereinafter called "ICU"), a holding company that has invested in, and controlled the hospitals and clinics of Columbia Asia Group in Malaysia, India, Indonesia and Vietnam (29 facilities in total) through its subsidiary, Columbia Asia Healthcare Pte. Ltd (hereinafter called "CAH"). Since the initial investment in Columbia Asia Group in July 2016, in collaboration with the founding family, Mitsui has enhanced the enterprise value of Columbia Asia Group through strategic initiatives such as profit maximization, growth plan development, corporate governance reinforcement and operational efficiency improvement, fully utilizing the strength of Columbia Asia Group platform to deliver high quality and efficient medical care to the respective communities. In March 2018, Mitsui acquired an additional equity stake in ICU, and has started to accelerate organizational optimization, hospital expansion, and IT system evolution.
ICU has entered into an agreement with HLT Healthcare Holdings Limited (A joint venture between Malaysian conglomerate, Hong Leong Group and the US PE fund, TPG) to separate the Indian operation (Columbia Asia Hospitals Private Limited) from CAH and subsequently divest CAH for the amount of approximately US$ 1.2 billion.
Mitsui is committed to leverage the experience and capability cultivated through the management of Columbia Asia Group, to resolve the supply-demand gap in the rapidly growing Asian healthcare market.
The expected profit relating to capital gain from this transaction is included in the business plan for the fiscal year ending March 2020, which was announced on April 26, 2019.

1. Profile of International Columbia U.S. LLC

2. Profile of Columbia Asia Group

3. Shareholding Structure (After separation of Indian operation)